ALPS Advisors’s Rocket Pharmaceuticals RCKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-52,273
Closed -$895K 1025
2023
Q1
$895K Sell
52,273
-1,096
-2% -$18.8K 0.01% 493
2022
Q4
$1.04M Buy
53,369
+17,339
+48% +$339K 0.01% 472
2022
Q3
$575K Sell
36,030
-3,024
-8% -$48.3K 0.01% 570
2022
Q2
$537K Sell
39,054
-27,240
-41% -$375K 0.01% 569
2022
Q1
$1.05M Sell
66,294
-8,283
-11% -$131K 0.01% 307
2021
Q4
$1.63M Sell
74,577
-3,393
-4% -$74.1K 0.02% 306
2021
Q3
$2.33M Sell
77,970
-5,133
-6% -$153K 0.02% 267
2021
Q2
$3.68M Sell
83,103
-28,669
-26% -$1.27M 0.03% 197
2021
Q1
$4.96M Buy
111,772
+12,019
+12% +$533K 0.05% 176
2020
Q4
$5.47M Buy
99,753
+29,372
+42% +$1.61M 0.06% 170
2020
Q3
$1.61M Sell
70,381
-4,865
-6% -$111K 0.02% 261
2020
Q2
$1.58M Sell
75,246
-23,245
-24% -$487K 0.02% 259
2020
Q1
$1.37M Sell
98,491
-2,975
-3% -$41.5K 0.02% 240
2019
Q4
$2.31M Buy
+101,466
New +$2.31M 0.02% 216
2018
Q4
Sell
-70,185
Closed -$1.73M 927
2018
Q3
$1.73M Buy
70,185
+13,008
+23% +$320K 0.01% 272
2018
Q2
$1.12M Buy
+57,177
New +$1.12M 0.01% 314
2017
Q2
Sell
-5,792
Closed -$46K 783
2017
Q1
$46K Sell
5,792
-678
-10% -$5.39K ﹤0.01% 727
2016
Q4
$158K Sell
6,470
-2,113
-25% -$51.6K ﹤0.01% 702
2016
Q3
$325K Sell
8,583
-697
-8% -$26.4K ﹤0.01% 640
2016
Q2
$276K Buy
9,280
+1,855
+25% +$55.2K ﹤0.01% 586
2016
Q1
$220K Sell
7,425
-1,273
-15% -$37.7K ﹤0.01% 600
2015
Q4
$394K Buy
+8,698
New +$394K ﹤0.01% 603